Cell Lysate Immunoassay

The capture antibody provides molecular selectivity within a complex protein mixture by binding the intended target rather than measuring total protein indiscriminately. This specificity allows researchers to distinguish one protein from many others present in the cell extract, supporting focused analysis of protein expression and biochemical changes.

After the target has been selectively bound, the labeled second antibody enables its detection through a measurable signal. Because the signal corresponds to the amount of target present, comparing signal levels between samples can reveal differences in protein abundance or changes associated with an experimental condition.

The assay can be designed to assess post-translational modifications or pathway activation, not only the presence of a protein. These measurements help connect biochemical changes to cellular signaling and provide more specific information about how cells respond during disease-related studies or drug-response experiments.

The workflow begins by disrupting cells under controlled conditions to produce an extract, followed by exposure of that lysate to a capture antibody. A second labeled antibody is then used to generate the readout. Measuring the resulting signal provides an estimate of the target protein in the sample.

Controlled cell lysis is important because the assay depends on the composition of the resulting extract. The lysate contains proteins released from the cells, and its quality directly affects the material presented to the capture antibody. Consistent disruption therefore supports meaningful comparisons across cultured-cell or tissue samples.

Researchers apply this approach to study signaling, disease mechanisms, drug responses, and protein-based biomarker validation. It is especially useful when the question concerns a specific protein, modification, or activation state within a complex cellular sample, allowing biochemical findings to be compared across experimental conditions.